Carley ME, Carley JM, Vasdev G, Lesnick TG, Webb MJ, Ramin KD, Lee RA. Factors that are associated with clinically overt postpartum urinary retention after vaginal delivery. Am J Obstet Gynecol 2002;187:430–433.

Carley ME, Cliby WA, Spelsberg TC. P2X3 receptor subunit messenger RNA expression in the female mouse bladder after oophorectomy with or without estrogen replacement. Am J Obstet Gynecol 2002;187:103–106.

Carley ME, Klingele CJ, Boldt KL, Gebhart JB. Concomitant urethral and uterovaginal prolapse in a postmenopausal woman. A case report. J Reprod Med 2002;47:939–942.

Carley ME, Klingele CJ, Gebhart JB, Webb MJ, Wilson TO. Laparoscopy versus laparotomy in the management of benign unilateral adnexal masses. J Am Assoc Gynecol Laparosc 2002;9:321–326.

Carley ME, McIntire D, Carley JM, Schaffer J. Incidence, risk factors and morbidity of unintended bladder or ureter injury during hysterectomy. Int Urogynecol J Pelvic Floor Dysfunct 2002;13:18–21.

Klingele CJ, Carley ME, Hill RF. Patient characteristics that are associated with urodynamically diagnosed detrusor instability and genuine stress incontinence. Am J Obstet Gynecol 2002;186:866–868.

Meath AJ, Carley ME, Wilson TO. Atypical glandular cells of undetermined significance. Review of final histologic diagnoses. J Reprod Med 2002;47:249–252.

Oncology, Hematology and Oncological Surgery

Baum M, O'Shaughnessy JA. Management of premenopausal women with early-stage breast cancer: is there a role for ovarian suppression? Clin Breast Cancer 2002;3:260–267.

Bramhall SR, Schulz J, Nemunaitis J, Brown PD, Baillet M, Buckels JA. A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer. Br J Cancer 2002;87:161–167.

Bukowski R, Ernstoff MS, Gore ME, Nemunaitis JJ, Amato R, Gupta SK, Tendler CL. Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II study. J Clin Oncol 2002;20:3841–3849.

Cunningham CC. New modalities in oncology: antisense oligonucleotides. BUMC Proceedings 2002;15:125–128.

Cunningham CC. New modalities in oncology: ribozymes. BUMC Proceedings 2002;15:247–249.

Cunningham CC. Paradigms in oncology, old and new. BUMC Proceedings 2002;15:123–124.
Denham CA. Locally advanced non–small-cell lung cancer. DMJ 2002;88:393–395.

DiPaola RS, Rinehart J, Nemunaitis J, Ebbinghaus S, Rubin E, Capanna T, Ciardella M, Doyle-Lindrud S, Goodwin S, Fontaine M, Adams N, Williams A, Schwartz M, Winchell G, Wickersham K, Deutsch P, Yao SL. Characterization of a novel prostate-specific antigen-activated peptide-doxorubicin conjugate in patients with prostate cancer. J Clin Oncol 2002;20:1874–1879.

Dresel A, Kuhn JA, McCarty TM. Sentinel node biopsy site used as full thickness skin graft donor for cutaneous melanoma. Am J Surg 2002;184:176–178.

Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus D, Meng S, Morrison L, Tucker T, Lane N, Ghadimi BM, Heselmeyer-Haddad K, Ried T, Rao C, Uhr J. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002;8:2073–2084.

Georges GE, Maris M, Sandmaier BM, Malone DG, Feinstein L, Niederweiser D, Shizuru JA, McSweeney PA, Chauncey TR, Agura E, Little MT, Sahebi F, Hegenbart U, Pulsipher MA, Bruno B, Forman S, Woolfrey AE, Radich JP, Blume KG, Storb R. Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases. Int J Hematol 2002;76(Suppl 1):184–189.

Holmes FA, Jones SE, O'Shaughnessy J, Vukelja S, George T, Savin M, Richards D, Glaspy J, Meza L, Cohen G, Dhami M, Budman DR, Hackett J, Brassard M, Yang BB, Liang BC. Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer. Ann Oncol 2002;13:903–909.

Holmes FA, O'Shaughnessy JA, Vukelja S, Jones SE, Shogan J, Savin M, Glaspy J, Moore M, Meza L, Wiznitzer I, Neumann TA, Hill LR, Liang BC. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol 2002;20:727–731.

Jones SE. Antiaromatase agents: evolving role in adjuvant therapy. Clin Breast Cancer 2002;3:33–42.

Jones SE. New developments in adjuvant hormonal therapy of early breast cancer. In Optimal Hormonal Therapy for Breast Cancer: Maximizing Efficacy and Tolerability. Seton Hall University and AACME, 2002:10–13.

Jones SE, Clark G, Koleszar S, Ethington G, Mennel R, Paulson S, Brooks B, Kerr R, Denham C, Savin M, Blum J, Kirby R, Stone M, Pippen J, George T, Orr D, Knox S, Grant M, Peters G, Savino D, Rietz C. Adjuvant chemotherapy with doxorubicin and cyclophosphamide in women with rapidly proliferating node-negative breast cancer. Clin Breast Cancer 2002;3:147–152.

Knox SM, Ley CA. Comparison of intraparenchymal and intradermal injection for identification of the sentinel node in breast cancer patients: results and follow-up. BUMC Proceedings 2002;15:366–368.

Kuhn J, McLoughlin J, Harris D, Talaasen L, Sutton S, McCarty T. Intraperitoneal hyperthermic chemotherapy: experience at Baylor University Medical Center. BUMC Proceedings 2002;15:359–362.

Lamont JP, Kakuda JT, Smith D, Wagman LD, Grannis FW Jr. Systematic postoperative radiologic follow-up in patients with non–small cell lung cancer for detecting second primary lung cancer in stage IA. Arch Surg 2002;137:935–938.

Levine JE, Braun T, Penza SL, Beatty P, Cornetta K, Martino R, Drobyski WR, Barrett AJ, Porter DL, Giralt S, Leis J, Holmes HE, Johnson M, Horowitz M, Collins RH Jr. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. J Clin Oncol 2002;20:405–412.

Maitra A, Gazdar AF, Moore TO, Moore AY. Loss of heterozygosity analysis of cutaneous melanoma and benign melanocytic nevi: laser capture microdissection demonstrates clonal genetic changes in acquired nevocellular nevi. Hum Pathol 2002;33:191–197.

Mennel RG. Clinical evaluation of the patient with an unknown primary tumor. In Perry MC, ed. American Society of Clinical Oncology 2002 Education Book. Baltimore: Lippincott Williams & Williams, 2002.

Morrow M, Vogel V, Ljung BM, O'Shaughnessy JA. Evaluation and management of the woman with an abnormal ductal lavage. J Am Coll Surg 2002;194:648–656.

Nemunaitis J. Live viruses in cancer treatment. Oncology (Huntingt) 2002;16:1483–1492.

Nemunaitis J, Cunningham C. Emerging new therapies for chemotherapy-resistant cancer using adenoviral vectors. Drug Resist Updat 2002;5:34–46.

Nemunaitis J, Edelman J. Selectively replicating viral vectors. Cancer Gene Ther 2002;9:987–1000.

Nemunaitis J, O'Brien J. Head and neck cancer: gene therapy approaches. Part 1: adenoviral vectors. Expert Opin Biol Ther 2002;2:177–185.

Nemunaitis J, O'Brien J. Head and neck cancer: gene therapy approaches. Part II: genes delivered. Expert Opin Biol Ther 2002;2:311–324.

Netto GJ. Tumors of unknown primary origin: the role of immunohistochemistry and molecular diagnostics. In Perry MC, ed. American Society of Clinical Oncology 2002 Education Book. Baltimore: Lippincott Williams & Williams, 2002:343–347.

Osborne CK, Pippen J, Jones SE, Parker LM, Ellis M, Come S, Gertler SZ, May JT, Burton G, Dimery I, Webster A, Morris C, Elledge R, Buzdar A. Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial. J Clin Oncol 2002;20:3386–3395.

O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub JP, Cervantes G, Fumoleau P, Jones S, Lui WY, Mauriac L, Twelves C, Van Hazel G, Verma S, Leonard R. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 2002;20:2812–2823.

O'Shaughnessy JA. Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy. Clin Breast Cancer 2002;3(Suppl 3):S116–S120.

O'Shaughnessy JA. Potential of capecitabine as first-line therapy for metastatic breast cancer: dosing recommendations in patients with diminished renal function. Ann Oncol 2002;13:983.
O'Shaughnessy JA, Gennari A, Conte P. Pemetrexed: a promising new treatment for breast cancer. Semin Oncol 2002;29(2 Suppl 5):36–41.

O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, Sigman CC, Bertagnolli MM, Stratton SP, Lam S, Nelson WG, Meyskens FL, Alberts DS, Follen M, Rustgi AK, Papadimitrakopoulou V, Scardino PT, Gazdar AF, Wattenberg LW, Sporn MB, Sakr WA, Lippman SM, Von Hoff DD. Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin Cancer Res 2002;8:314–346.

O'Shaughnessy JA, Ljung BM, Dooley WC, Chang J, Kuerer HM, Hung DT, Grant MD, Khan SA, Phillips RF, Duvall K, Euhus DM, King BL, Anderson BO, Troyan SL, Kim J, Veronesi U, Cazzaniga M. Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary. Cancer 2002;94:292–298.

Pippen J. Locally advanced carcinoma of the breast treated with docetaxel, doxorubicin, and pegfilgrastim. Case Studies in Breast Cancer 2002;1(3).

Stone MJ. Myeloma and macroglobulinemia: what are the criteria for diagnosis? Clin Lymphoma 2002;3:23–25.

Stratmann SL. Hepatic artery chemotherapy in the management of colorectal metastases. BUMC Proceedings 2002;15:376–379.

Sutton SW, Yancey LW, Chase VA, Hunley EK, McCarty TM, Kuhn JA, Loggie BW. Intraoperative modality of treatment for peritoneal carcinomatosis: use of hyperthermic interperitoneal chemoperfusion. Perfusion 2002;17:441–446.

Van Cutsem E, Hoff PM, Blum JL, Abt M, Osterwalder B. Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil. Ann Oncol 2002;13:484–485.

Ophthalmology

Gokmen F, Jester JV, Petroll WM, McCulley JP, Cavanagh HD. In vivo confocal microscopy through-focusing to measure corneal flap thickness after laser in situ keratomileusis. J Cataract Refract Surg 2002;28:962–970.

Hargrave SL, Jung JC, Fini ME, Gelender H, Cather C, Guidera A, Udell I, Fisher S, Jester JV, Bowman RW, McCulley JP, Cavanagh HD. Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis. Ophthalmology 2002;109:343–350.

Kozielec G. Age-related macular degeneration. DMJ 2002;88:18–18.

Wang X, McCulley JP, Bowman RW, Cavanagh HD. Time to resolution of contact lens-induced corneal warpage prior to refractive surgery. CLAO J 2002;28:169–171.

Wang X, McCulley JP, Bowman W, Cavanagh HD. Results of combined myopic astigmatic LASIK treatment and retreatments. CLAO J 2002;28:55–60.

Wang X, Shen J, McCulley JP, Bowman RW, Petroll WM, Cavanagh HD. Intraocular pressure measurement after hyperopic LASIK. CLAO J 2002;28:136–139.

DeFrino PF, Brodsky JW, Pollo FE, Crenshaw SJ, Beischer AD. First metatarsophalangeal arthrodesis: a clinical, pedobarographic and gait analysis study. Foot Ankle Int 2002;23:496–502.

Flatt AE. Our thumbs. BUMC Proceedings 2002;15:380–387.

Jackson RW. Arthroscopic surgery for osteoarthritis of the knee. N Engl J Med 2002;347:1717–1719.

Jackson RW.The evolution of orthopaedic surgery. In Arthroscopy and Arthroscopic Surgery. London: Royal Society of Medicine Press, 2002:39–47.

Komdeur P, Pollo FE, Jackson RW. Dynamic knee motion in anterior cruciate impairment: a report and case study. BUMC Proceedings 2002;15:257–259.

Meador R, Ehrlich G, Von Feldt JM. Behcet's disease: immunopathologic and therapeutic aspects. Curr Rheumatol Rep 2002;4:47–54.

Meador R, Hsia E, Kitumnuaypong T, Schumacher HR. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol 2002;20(6 Suppl 28):S130–S134.

Pollo FE, Otis JC, Backus SI, Warren RF, Wickiewicz TL. Reduction of medial compartment loads with valgus bracing of the osteoarthritic knee. Am J Sports Med 2002;30:414–421.

Sherk HH, Vangsness CT, Thabit G III, Jackson RW. Electromagnetic surgical devices in orthopaedics. Lasers and radiofrequency. J Bone Joint Surg Am 2002;84-A:675–681.